GE Healthcare has entered the home-care segment with a $50 million strategic investment in Israeli startup Pulsenmore, a developer of handheld teleultrasound devices.
Pulsenmore's handheld teleultrasound device docks with a smartphone, allowing women to perform ultrasound self-scans at home and receive fast clinical feedback from healthcare professionals.
The investment is aimed at accelerating global adoption of Pulsenmore's home-care ultrasound products and will also support the company's goal to pursue U.S. Food and Drug Administration clearance and commercial expansion.
The investment ultimately aims to help increase peace of mind for expectant mothers and reduce in-person visits, GE said.
